GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/CAMs and GI Disorders
84

CAMs and GI Disorders

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated July 1, 2025

Complementary and Alternative Medicine (CAM) is increasingly being recognized as a valuable adjunct in the management of gastrointestinal (GI) disorders, particularly as the prevalence of these conditions rises due to modern lifestyle factors such as stress, ultraprocessed diets, obesity, depression, and infections. Below is a detailed exploration of the role of CAM in GI disorders, supported by the context provided:


Prevalence of CAM Use in GI Disorders

  • Widespread Use: Up to 44% of patients with GI disorders use CAM therapies, often without informing their healthcare providers. This highlights the need for physicians to proactively inquire about CAM use to avoid risks of hidden interactions and to provide appropriate guidance.
  • Patient Appeal: CAM is attractive to patients because it offers a sense of control, especially when conventional treatments fail to fully resolve symptoms. The holistic approach of CAM addresses not just physical symptoms but also psychological and lifestyle factors.

Barriers and Opportunities in CAM Integration

  • Disclosure Gap: Many patients do not disclose their use of CAM due to fear of judgment or the belief that it is not clinically relevant, which can lead to missed opportunities for physicians to guide safe and effective use.
  • Educational Gap: CAM is rarely covered in medical training, leaving many gastroenterologists unfamiliar with therapies their patients are actively using. Bridging this gap through education and awareness is essential.
  • Integrative Model: Experts advocate for an integrative gastroenterology model, combining standard medical care with evidence-based CAM therapies to address the growing burden of GI diseases.

Evidence-Based CAM Therapies for GI Disorders

  1. Mind-Body Medicine:
  • Interventions like cognitive behavioral therapy (CBT), mindfulness, hypnotherapy, and yoga have demonstrated efficacy in functional GI disorders like irritable bowel syndrome (IBS).
  • These therapies are gaining mainstream acceptance as scientific evidence accumulates, particularly in their ability to address the neuro-gut connection.
  1. Nutritional Supplements and Herbal Therapies:
  • L-Glutamine: Effective in postinfectious IBS with diarrhea and intestinal hyperpermeability, supporting gut barrier repair.
  • Ginger and Vitamin B6: Evidence-supported treatments for nausea, including pregnancy-related nausea, though caution is advised for ginger in patients on antiplatelet therapy.
  • Peppermint and Caraway: Extensively studied for functional dyspepsia, with significant reductions in bloating and epigastric pain.
  • Curcumin: Known for its anti-inflammatory effects in the GI tract.
  • Bovine Colostrum: Supports mucosal immunity and healing.
  • Mucosal Protectants: Compounds like zinc-carnosine, marshmallow root, slippery elm, and licorice support gut barrier function and reduce inflammation. These may also be useful in transitioning patients off proton pump inhibitors (PPIs).
  1. Probiotics:
  • Specific strains, such as Saccharomyces boulardii, help prevent dysbiosis during antibiotic therapy. Targeted probiotics can also be used post-treatment to restore gut health.
  1. Acupuncture:
  • Widely studied in various GI disorders such as constipation, GERD, IBD, ileus, pancreatitis, and gastroparesis.
  • Functional MRI studies show acupuncture modulates brain connectivity in regions associated with visceral sensation, pain regulation, and emotion, providing mechanistic plausibility for its efficacy.
  1. Herbal Combinations:
  • STW-5 (Iberogast): A combination of multiple herbs, shown to improve symptoms in GERD and epigastric pain, with clinical trials supporting its efficacy.

Lifestyle and Behavioral Guidance

  • CAM practitioners emphasize the importance of lifestyle changes to complement medical and CAM treatments. Key recommendations include:
  • Eating slowly and mindfully.
  • Reducing greasy and processed foods.
  • Avoiding lying down immediately after meals.
  • Ensuring adequate fiber intake.

These strategies not only help manage symptoms but also address underlying contributors to GI disorders.


Evolving Acceptance of CAM in GI Disorders

  • Therapies once considered fringe, such as mind-body medicine and concepts like intestinal permeability ("leaky gut"), are gaining legitimacy as scientific evidence accumulates.
  • The integrative approach to gastroenterology is increasingly recognized for its potential to accelerate symptom relief, reduce reliance on medications, and improve overall quality of life for patients with functional and inflammatory GI disorders.

Concerns with Overuse of Conventional Treatments

  • Overprescription of proton pump inhibitors (PPIs) is a concern, as they are often prescribed without confirming true hyperacidity. This can lead to risks like infections, nutrient malabsorption, and rebound hyperacidity. CAM therapies, such as mucosal protectants and lifestyle changes, may serve as alternatives or adjuncts to reduce reliance on PPIs.

Clinical Implications

Gastroenterologists should:

  1. Proactively inquire about CAM use during patient consultations.

  2. Stay informed about evidence-based CAM therapies to provide safe and effective recommendations.

  3. Integrate CAM with standard care to offer a holistic approach to managing GI disorders.

By combining conventional medicine with evidence-supported CAM, healthcare providers can address both the physical and psychological dimensions of GI disorders, ultimately improving patient outcomes and satisfaction.

Related Q&A

85

Sarcopenia in Crohn's Disease

Sarcopenia in Crohn's Disease (CD), particularly in pediatric patients, is a significant clinical concern. Below is a detailed summary of its prevalence, prognostic value, clinical implications, and management...

86

Proteome-Based Biopsy Scoring for Mucosal Remodeling in Celiac Disease

Proteome-Based Biopsy Scoring for Mucosal Remodeling in Celiac Disease refers to a novel approach that utilizes mass spectrometry–based proteomics to assess mucosal changes in the small intestine of...

87

Prediction Models for Early Celiac Disease in Genetically Susceptible Children

The study titled "Prediction Models for Early Celiac Disease in Genetically Susceptible Children" comes from the PreventCD project, which aimed to understand and predict the development of celiac...

88

CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis

CD19 CAR T-cell therapy, a treatment traditionally used for certain types of B-cell malignancies, has shown promise in a case of severe, multidrug-resistant ulcerative colitis (UC). This novel...

89

ARFID and IBD

Avoidant/restrictive food intake disorder (ARFID) and inflammatory bowel disease (IBD) share a complex relationship. ARFID is an eating disorder characterized by restrictive eating patterns often driven by anxiety,...

90

PLANET study

The PLANET study is a research initiative that is prospectively investigating the exposure to micro- and nanoplastics in pregnant women and their children. It is part of the...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer